In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.

Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistant Candida strains are...

Full description

Bibliographic Details
Main Authors: Sarah Sze Wah Wong, Richard Yi Tsun Kao, Kwok Yong Yuen, Yu Wang, Dan Yang, Lakshman Perera Samaranayake, Chaminda Jayampath Seneviratne
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3899067?pdf=render